FEATURED ARTICLES

NEWS ROUNDUP: Pharma Invests In Patients, More Trials Use FitBit Trackers
NEWS ROUNDUP: Pharma Invests In Patients, More Trials Use FitBit Trackers

Clinical Leader news roundup for the week of April 11, 2016, with articles on pharma’s investment in patients, FitBit activity trackers in clinical trials, new Hep C combination treatment tested in Malaysia and Thailand, prostate and pancreatic cancer trials, the need for clinical trial participants, and making the most of clinical trial data.

  • How Do I Get My Compound Into Phase I?
    How Do I Get My Compound Into Phase I?

    The primary challenge for pharmaceutical and biotechnology companies in developing their drugs is to carefully assess the relationship between efficacy and toxicity prior to entering into human clinical trials. By Dr. Scott E. Boley and Greg Ruppert

  • Will Protagonist Be The Hero In Making Stable Oral Peptides To Replace Injectables?
    Will Protagonist Be The Hero In Making Stable Oral Peptides To Replace Injectables?

    Protagonist Therapeutics has created a technology for making stable oral peptides capable of replacing injectable-only drugs and is developing entirely new oral-peptide therapeutics  or GI patients. Its initial development areas are irritable bowel diseases (IBD) and irritable bowel syndrome (IBS). Two compounds, one an injectable peptide to block IL-6, and another, an oral peptide to block integrins, will enter clinical trials in 2015.

  • Can Rapid Mobile Diagnostics Speed Up Clinical Trials And Regulatory Reviews?
    Can Rapid Mobile Diagnostics Speed Up Clinical Trials And Regulatory Reviews?

    As a new technological space containing all the alternatives, the most practical and immediate application for Rapid Mobile Diagnostics (RMDx) may be in clinical trials.

More Featured Articles

WHITE PAPERS & CASE STUDIES

  • Gastroenterology Endoscopic Expertise Sheet

    Endoscopy plays a key role in evaluating the efficacy and safety of new drugs for Inflammatory Bowel Disease (IBD) and determining patient eligibility for gastroenterology clinical trials.

  • Strategic Clinical Outsourcing Considerations: The Interdependency Of Clinical Drivers

    A solid outsourcing strategy is critical to leading your organization to a successful outsourcing experience. Of course every organization in need of outsourced services must consider their priorities: Is it cost? Timelines? Team experience? Some combination? Inevitably the salient considerations are a combination of each of these factors, yet some will be weighed more heavily than others. By Kevin Boos, RDP Clinical Outsourcing, Scott Connor, Acurian, and Meenal Patel, RDP Clinical Outsourcing

  • Leveraging Investigator Grant Payment Practices To Enhance Sponsor-Site Relationships

    One of the world’s leading pharmaceutical companies, AstraZeneca, has over 67,000 employees. Among those are about 13,000 at 17 principal research and development centers in eight countries — including the United States.

  • ICON Clinical Development Overview

    ICON is one of the world’s largest providers of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies.

  • List Of Laboratory Biomarkers

    The biomarker menus include a sampling of our most frequently requested markers of efficacy, exposure, response and susceptibility. 

  • Clinical Research Management Phase IIb-IV

     ICON Clinical Research is a division of ICON plc. It specializes in the planning management, execution, and analysis of Phase IIb–IV clinical trials, ranging from small
    studies to complex, multinational projects.

More White Papers & Case Studies

SERVICES & PRODUCTS

Gastroentrology Gastroentrology
Gastroentrology
Clinical Research Volunteer Recruitment Clinical Research Volunteer Recruitment

ICON has a harmonised network of 3 Clinical Pharmacology Units which enables us to offer rapid, flexible recruitment solutions that are managed utilising our "access to volunteers strategy" and robust risk management model.

Therapeutic Areas Therapeutic Areas
PAREXEL has a wealth of experience conducting pivotal clinical trials in all the major therapeutic areas. Our global experience and resources are essential for conducting cost-efficient and timely trials for your novel therapies.
Medical Writing Medical Writing
Each member of our core medical writing team draws on extensive industry knowledge and therapeutic expertise to effectively meet our clients' requirements.
Internal Medicine Internal Medicine
Clinical trial design, site selection, enrollment speed, regulatory hurdles, market access challenges, and commercial adoption are just some of the challenges that must be overcome to achieve success for a product development program.
More Services & Products

NEWS

More News